Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound localisation microscopy tracks testicular microvascular adaptations to endocrine function in male infertility.

EBioMedicine·2026
Same author

The effectiveness of hormonal treatment to improve reproductive outcomes in normo-gonadotropic men with abnormal semen parameters: Results of two linked systematic reviews.

The Journal of clinical endocrinology and metabolism·2026
Same author

Clinical features of androgen abuse withdrawal in men during the first year of cessation: a community dwelling study.

The Journal of clinical endocrinology and metabolism·2026
Same author

Obesity in menopause care.

European journal of endocrinology·2026
Same author

Discordance Between Online Information and Male Hypogonadism Clinical Guidelines: A Global Multilingual Content Analysis.

The Journal of clinical endocrinology and metabolism·2026
Same author

Synthesizing the latest guideline-based recommendations for the management of female hypogonadism.

Archives of endocrinology and metabolism·2025
Same journal

Glucagon-like peptide-1 and diabetes 2012.

Experimental diabetes research·2013
Same journal

Impact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysis.

Experimental diabetes research·2013
Same journal

Autonomic nervous system, inflammation, and diabetes: mechanisms and possible interventions.

Experimental diabetes research·2013
Same journal

5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes.

Experimental diabetes research·2013
Same journal

Animal models of diabetes mellitus for islet transplantation.

Experimental diabetes research·2013
Same journal

Noncoding RNAs.

Experimental diabetes research·2013
See all related articles

Related Experiment Video

Updated: May 19, 2026

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

Obesity and appetite control.

Keisuke Suzuki1, Channa N Jayasena, Stephen R Bloom

  • 1Section of Investigative Medicine, Imperial College London, Commonwealth Building, Du Cane Road, London W12 0NN, UK.

Experimental Diabetes Research
|August 18, 2012
PubMed
Summary
This summary is machine-generated.

Obesity is a global health challenge lacking effective drug treatments. This study explores how gut hormones and brain signaling pathways (the gut-brain axis) control appetite, offering potential new obesity therapies.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

Related Experiment Videos

Last Updated: May 19, 2026

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

Area of Science:

  • Neuroscience
  • Endocrinology
  • Metabolic Research

Background:

  • Obesity presents a significant global health challenge with limited pharmacological interventions.
  • Energy homeostasis is regulated by complex neurohumoral networks connecting the brain and gut.
  • The hypothalamus integrates peripheral signals and cortical/brainstem pathways to control food intake and energy expenditure.

Purpose of the Study:

  • To investigate the role of gut hormones and the gut-brain axis in appetite control.
  • To explore the potential of targeting these pathways for novel obesity therapies.

Main Methods:

  • Review of recent studies on energy homeostasis and neurohumoral signaling.
  • Focus on the gut-brain axis, including gut hormones (e.g., peptide YY, ghrelin, leptin) and their neuronal networks.
  • Analysis of hypothalamic integration of peripheral and central signals.

Main Results:

  • Gut hormones (peptide YY, ghrelin, etc.) are modulated by food ingestion.
  • Adiposity signals (leptin, insulin) influence both short- and long-term energy balance.
  • The hypothalamus acts as a central hub for integrating appetite-regulating signals.

Conclusions:

  • The gut-brain axis, mediated by gut hormones and neuronal networks, plays a critical role in appetite regulation.
  • Understanding these pathways offers promising avenues for developing new pharmacological treatments for obesity.